Ftse Mib
36.171,21
0,31%
DAX
21.267,09
1,07%
S&P 500
6.049,24
0,88%
NASDAQ
19.756,78
0,64%
Bitcoin
105.043,00
-1,06%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Trinity Biotech PLC (TRIB) Trinity Biotech PLC (TRIB) Notizie

Trinity Biotech PLC

TRIB
0,805
0,00 (0,00%)
22 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
27/12/202422:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/12/202422:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
27/12/202400:19EDGAR2Form SCHEDULE 13D - General Statement of Acquisition of..
24/12/202414:33GLOBETrinity Biotech Announces Amended Credit Agreement with..
20/12/202403:55EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
18/12/202418:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/12/202417:00GLOBETrinity Biotech Receives Early Approval from the World..
17/12/202422:56EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/12/202422:42EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
05/12/202422:30EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
29/11/202422:45EDGAR2Form F-3/A - Registration statement by foreign private..
15/11/202423:00EDGAR2Form F-3 - Registration statement by foreign private issuers
15/11/202419:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/11/202415:00GLOBETrinity Biotech Announces Q3 2024 Financial Results
14/11/202423:26EDGAR2Form SC 13D/A - General Statement of Acquisition of..
07/11/202418:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/11/202414:19GLOBETrinity Biotech Regains Compliance with Nasdaq Listing..
25/10/202419:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/10/202419:23EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/10/202414:45GLOBETrinity Biotech Enters Oncology Space with Acquisition of..
07/10/202416:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/10/202414:15GLOBETrinity Biotech Announces Positive Pre-Pivotal Trial Results..
02/10/202417:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/9/202421:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/9/202412:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/9/202422:05GLOBETrinity Biotech Announces Acquisition of Metabolomics..
23/9/202414:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/9/202423:14EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19/9/202412:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/9/202422:05GLOBETrinity Biotech to Initiate CGM Market Study in India in..
10/9/202416:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/9/202422:05GLOBETrinity Biotech Provides an Update on the Continued..
05/9/202419:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/9/202416:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/9/202417:59EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/9/202415:55GLOBETrinity Biotech Appoints Global Life Sciences Leader as..
29/8/202412:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/8/202423:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
27/8/202418:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/8/202422:05GLOBETrinity Biotech Announces Increased Orders for TrinScreen..
21/8/202422:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/8/202423:00GLOBETrinity Biotech Appoints Diabetes Care Veteran as Biosensor..
20/8/202419:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/8/202413:30GLOBETrinity Biotech Announces Q2 2024 Financial Results
13/8/202422:05GLOBETrinity Biotech to Announce Q2 2024 Financial Results
07/8/202423:27EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/8/202423:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/8/202422:05GLOBETrinity Biotech Obtains an Extension to Demonstrate..
02/8/202415:24GLOBETrinity Biotech Provides Preliminary Second Quarter 2024..
12/7/202423:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
Apertura: Min: Max:
Chiusura: 0,805

La tua Cronologia

NASDAQ
TRIB
Trinity Biotech
LSE
JAPB
Lyxor Core Jap
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network